gc1109
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT01867957)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Bacillus anthracisImmunity, active
Bacillus anthracis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gc1109
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01867957 | Phase 1 | Feb 1, 2009 | Green Cross Corporation, LSK Global Pharma Services Co. Ltd., Seoul National University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Green Cross Corporation | For profit | 1 | 0 | 1 | 2009 |
| LSK Global Pharma Services Co. Ltd. | For profit | 1 | 0 | 1 | 2009 |
| Seoul National University | Academic/Hospital | 1 | 1 | 1 | 2009 |
3 organizations
Page 1 / 1